Stephen Squinto

Stephen Squinto is the Chief Investment Officer and Managing Partner of JP Morgan Life Sciences Private Capital, bringing over thirty years of biotechnology experience to his current leadership role. He began his career as a scientific founder and early team member at Regeneron Pharmaceuticals before co-founding Alexion Pharmaceuticals, where he served as Executive Vice President and Chief Global Operations Officer. Prior to joining JP Morgan in 2022, he spent eight years as an Executive Partner at OrbiMed Advisors, serving on up to twenty company boards and operating as an executive for five portfolio companies. He earned his degrees in Chemistry, Biochemistry, and Biophysics from Loyola University of Chicago following early academic positions at Tulane University and Louisiana State University medical schools. Today, his primary investment focus centers on life sciences, healthcare private capital, rare disease therapeutics, and genomics innovation.